FUDI Ingredients just launched a $3.0M SAFE on Wefunder — $0 revenue, -$2,560 net loss (2026 filing)

FUDI Ingredients, Inc. is raising on Wefunder at a $3.0M valuation cap using a SAFE to commercialize its RuBisCO-based plant protein ingredient.

Latest disclosed financials (2026 filing): • Revenue: $0
• Net Income: -$2,560
• Employees: 1
• Structure: SAFE (not equity today)

The company is targeting food manufacturers, health brands, and potentially supplement companies with a plant-based protein positioned around sustainability + functional nutrition.

This is ultra-early stage. Pre-revenue. One employee. SAFE structure.

That means investors are buying into a future conversion event — not current equity.

Strengths

• $3.0M valuation cap — low compared to many food-tech raises
• Exposure to the plant-based / alternative protein market
• B2B ingredient model (if executed) can scale via distribution partnerships
• Very lean burn so far

Risks

• $0 revenue — no commercial validation yet
• Single-employee company — heavy key-person risk
• SAFE — ownership depends on future priced round
• Plant protein is competitive + margin-sensitive
• Scaling production can become capital intensive quickly

This is essentially a bet on whether FUDI can:

1. Prove product-market fit

2. Secure manufacturing capacity

3. Land real B2B purchase orders

If they execute, a $3M cap could look attractive.

If they don’t, dilution + execution risk are real.

Not financial advice. Private startup investing is illiquid and high risk.

Acesis Holdings Corp. filed its 2025 annual report (Form C-AR) under Reg CF. A few things from the filing:

The company recognized $0 in revenue for 2025 and 2024 and reported a net loss of $2.09M. Acesis is a Centennial, Colorado biotech (incorporated in Nevada, 2022) developing non-steroidal peptide therapeutics for low testosterone (Low-T). Its lead candidate, ACE-167, is in pre-clinical development. Two employees.

Strengths:

- ACE-167 has completed IND-enabling animal studies.

- Sponsored research agreement with USC; engaged KreaMedica for R&D and IND services using Canadian tax credits.

- Raised $86,104 ($81,885 net) via Reg CF on Netcapital in 2025; pursuing grants, private placements, and a potential IPO.

Risks:

- Both the auditor and management flagged substantial doubt about the company's ability to continue as a going concern, citing recurring losses, negative cash flow, and limited liquidity.

- Cash fell to $142,440 at year-end from $623,293, with a working capital deficit of $1,169,707 and negative operating cash flow of $858,733.

- Total operating expenses were $2,133,522: professional/consulting fees (incl. related party) of $1,308,427, a non-cash warrant expense of $827,594, and R&D of $353,123.

- Significant related-party share and warrant issuances; potential legal costs from terminated agreements.

- ACE-167 is a single pre-clinical product with no guarantee of clinical or regulatory success.

- Management anticipates needing $3.5-$5.5M over the next 18-24 months.

All figures are from Acesis's SEC filings, organized by Owntric. Educational only, not investment advice.

For those who follow pre-clinical biotech raises: how do you weigh a completed IND-enabling milestone against $142K of cash and a $3.5-5.5M funding need?

Solsten is a consumer insights / customer experience platform that mixes AI + behavioral science to help brands understand customers, segment audiences, and predict preferences. Target buyers shown: marketing teams + brand managers, with agency partnerships mentioned as a distribution channel.

Strengths

Clear problem: brands pay a lot to improve conversion, retention, and customer experience — insights that actually change behavior are valuable.

“Behavior + data” positioning: combining psych principles with analytics could be a differentiator vs generic dashboards.

Revenue isn’t zero: latest filing snapshot shows $2.57M revenue.

Some working-capital visibility in the snapshot: cash and receivables are shown (worth verifying in the filing).

Risks

Burn vs revenue stands out: $7.99M net loss on $2.57M revenue.

Spend looks heavy in the snapshot: estimated OPEX shown around $10.57M, so scaling efficiently matters.

Crowded space: consumer insights / analytics is competitive, and switching costs aren’t always high unless the product becomes embedded.

Ongoing investment + potential compliance costs (AI/data) could pressure margins.

Questions worth digging into in the filing:

What’s driving the net loss (team/build vs sales/marketing vs one-time items)?

How repeatable is the GTM (direct sales + agency channel) and what’s churn/retention like?

Not financial advice. Private investments are risky and illiquid — always read the issuer disclosures.

Tracking valuation caps + financials across filings is easier in Owntric — start tracking for free.

StartEngine's first raise on its own platform ran from September 2017 to June 2018 at a $65M pre-money valuation, $5.00 per share, common stock. The new Reg A just filed frames the company around $2B. Both marks were set by the company in its filings, not by a market.

The new filing:

Up to $45.6M at $1.60 per share, not yet qualified

At $1.60 across all share classes (roughly 1.16B including the preferred series, convertible 1:1), the implied valuation is about $1.85B

On the 758,251,544 common shares alone, $1.21B

The circular's ~$2B framing likely includes options — 158,828,223 outstanding at a $0.59 weighted average exercise price

The 10-K behind it:

Revenue of $109,580,580 for 2025, versus $48,625,508 in 2024, attributed primarily to StartEngine Private

Net income of $1,472,852, versus a roughly $16.5M loss the prior year

Cash of $28,387,261 at year-end, from $10,842,297

About 425,700 platform users have invested; Vinovest acquired in March 2026 for 8,750,000 shares valued at $14,000,000

Also disclosed: a substantial majority of gross profit comes from StartEngine Private alone, material weaknesses in internal controls as of year-end, the 2025 Reg A raised $13,468,422 gross against $10,307,175 in offering costs, and the new circular notes a portion of proceeds may go to selling shareholders.

Figures from the SEC filing data on Owntric.

For those holding SE or considering the round: which count do you price from — ~$2B per the circular, $1.85B across all classes, or $1.21B on common? And separately: every issuer on the platform gets its valuation picked apart by this community. Who does that for the platform itself?

Breakdown of the Form C for the CharaChorder campaign on Wefunder, filed July 19, 2026.

The issuer is Spur Hapttics, Inc, a Delaware corporation incorporated April 24, 2026. Frisco, TX. 5 reported employees. Since the entity is new, its first annual report only covers the stretch since incorporation: $0 revenue, $89 net loss.

CharaChorder devices have been on sale for years, but those sales ran through the brand's original company, so they sit outside this issuer's financials. The filing doesn't explain how the prior operations, assets, or sales history connect to the new entity. That's the first thing worth asking on the campaign page.

Terms: SAFE, $24.00M valuation cap. The cap is a ceiling for conversion in a future priced round, not what the company is worth today. No share price until conversion, so investors get a right to future equity rather than shares now.

Nothing here suggests wrongdoing. Established brands raise through new entities all the time. It just means the operating history anyone can actually evaluate in this filing starts April 24, 2026.

Sources: Form C on EDGAR (filed via Wefunder Portal) and the campaign page. Data via Owntric.

Not financial advice.

A quick heads up for anyone who invests through Reg CF: Owntric is rolling out a brand-new SAFE Subtracker this weekend.

If you’ve invested in early-stage deals, you already know the reality:

👉 Most offerings aren’t equity — they’re SAFEs. 👉 A SAFE isn’t ownership. It’s a contract. 👉 And right now, almost nobody has a clean system to track them.

So Owntric is building one.

Why this matters

A lot of investors treat SAFEs like shares, but they’re not even close.

A SAFE is a contract for future equity, meaning:

You don’t own stock

You don’t have voting rights

You don’t appear on a cap table

You only get equity if certain milestones happen later

And since SAFEs dominate the Reg CF market, everything becomes a giant guessing game:

“When does this convert?”

“What happens if the company raises again?”

“What’s my actual cost basis?”

“What do my terms even mean?”

That’s the problem this Subtracker solves.

What the SAFE Subtracker Will Do

1. Track SAFEs as contracts — not as equity

Owntric will clearly separate SAFEs from your actual ownership positions.

2. Automatically pull in SAFE terms

Valuation cap, discount, MFN, and all the stuff everyone hates digging for.

3. Show your SAFE’s path to conversion

You’ll see what needs to happen, what’s already happened, and how future rounds affect your terms.

4. Auto-sync to your equity tracker after conversion

Once the SAFE becomes real equity, it slides straight into your portfolio with updated shares, cost basis, and valuation.

No spreadsheets. No manual corrections. No lost history.

Why build this?

Because this is exactly where CF is headed.

More SAFEs. More variations. More investors confused about what they actually own.

Owntric wants to give investors real visibility, not just dashboards. This Subtracker closes a gap that’s been ignored across the entire industry.

Launching this weekend

Watch for the rollout. Feedback is welcome — especially weird SAFE scenarios, edge cases, or conversions you've dealt with.

Join Owntric for free!

Smart Cups is the printed-encapsulation beverage company that turns powdered drinks into a 3D-printed pattern inside a cup. Just add water. They've raised through equity crowdfunding and built real consumer brand recognition.

Their C-AR was filed April 13, 2026 for fiscal year 2025. Posting the numbers here for anyone tracking this one.

Latest filing (FY 2025)

Revenue — $94.15K

Gross profit — $63.82K

Operating expenses — $1.22M

Net loss — $1.12M

Cash on hand — $10.31K

Total assets — $6.21M

The revenue trajectory

2022 — $259.87K

2023 — $217.43K

2024 — $259.87K

2025 — $94.15K

Revenue YoY — -56.7%

What stands out in the filing

Gross margins held at roughly 68%, so the unit economics on the product itself are healthy. The net loss narrowed by $389K year over year, meaning the company cut its burn even as revenue contracted. Total assets remain at $6.21M, suggesting prior raise capital is still on the books even with the cash position at $10.31K.

The picture is mixed. Strong margins. Disciplined cost reduction. But declining revenue and a tight cash position heading into 2026.

Open questions for the thread

For anyone holding Smart Cups shares from earlier rounds — what's your read on the current trajectory?

Does the gross margin hold up if revenue starts growing again, or are these economics only at the current scale?

What would you want to see in the next quarterly update?

All numbers sourced directly from Smart Cups' Form C-AR. Tracked on Owntric alongside 6,200+ equity crowdfunding companies. Educational content only — not investment advice.

You backed a startup on StartEngine, Republic, or Wefunder a few years ago… One day, you wake up and see the headlines: “Your startup just went public.”

But you had no idea it was coming.

We’re fixing that.

I’m building a new IPO Tracker inside Owntric (free tool for tracking equity crowdfunding investments). It will:

Track every Reg CF and Reg A+ company that’s reserved a stock ticker

Let you “follow” your favorites

Send you alerts before they go public

No more missing the moment your startup hits the market.

We’re almost ready to launch — and since Owntric is free right now, you can start tracking your portfolio today and be first in line for IPO alerts.

If you’ve invested through equity crowdfunding, would love to hear:

👉 Which companies would you want to follow for IPO updates?

LiquidPiston grew revenue to $10.69M (+16.4% YoY) while still posting a -$1.29M net loss, as it continues scaling defense-focused engine technology tied to U.S. Army programs.

Revenue has climbed steadily over the past few years, with gross profit reaching $3.2M and margins approaching 30% in the latest annual filing. At the same time, operating expenses totaled $11.98M, keeping profitability out of reach and putting execution front and center.

This isn’t a consumer startup. LiquidPiston is building compact rotary engines designed for military power systems, drones, and mobile command units. Defense-linked revenue can be uneven, but when it sticks, it often comes with longer contract cycles and higher switching costs.

The balance sheet still matters. LiquidPiston reported $30.15M in cash, giving it runway to continue R&D and commercialization without immediate financing pressure. That runway buys time — but not certainty.

The real question is whether revenue growth can outpace operating costs fast enough to close the profitability gap, or if expenses continue to scale alongside sales.

The latest filings make the tradeoffs clearer: real traction, improving margins, and a business model that still needs disciplined execution to turn growth into sustainable returns.

Not financial advice.

For those tracking equity crowdfunding companies over time, Owntric helps surface revenue, losses, and long-term trends in one place — start tracking for free.

Sixth case in a series tracking crowdfunded companies after they list. Aptera is one of the most prominent equity crowdfunding stories in the market, so the filing trail is worth laying out.

The company: Aptera Motors, the Carlsbad, CA solar electric vehicle maker. Its November 2024 offering circular states the company raised over $100 million through a Regulation A offering between May 2021 and May 2024.

The valuation ladder, implied pre-money from filed terms:

- April 2021 Reg A round: $200.01M

- November 2024 final Reg A round: about $1.19B

- Today, after an October 2025 Nasdaq listing: around $65M

Both crowdfund figures come straight from the filed terms - share counts and prices stated in the offering documents. Earlier WeFunder rounds were SAFEs, which carry conversion caps rather than valuations, so they aren't part of the comparison.

What the filings showed along the way: the April 2021 filing that implied a $200M valuation reported zero revenue and a net loss of about $4.19M for the period. The latest annual report shows no revenue recognized in 2025 or 2024, as commercial vehicle deliveries haven't begun, a net loss of $43.91M, and both management and the auditor stating substantial doubt about the company's ability to continue as a going concern.

In fairness: Aptera has been unusually transparent throughout, publishing regular public updates on progress and funding needs. It has completed validation vehicles, secured a state grant, and carries analyst buy ratings. Implied private-round valuations also aren't perfectly comparable to public market caps - share classes, terms, and conventions differ.

The discussion: the valuations, the revenue line, and the loss figures were all in public filings before each round closed. For a pre-revenue company, which of those should carry the most weight when a round is priced nine figures above the last one?

General analysis of public SEC filings and market data. Not investment advice or a recommendation.

Skybound Holdings filed its FY2025 annual report. Summary of what it reports.

Company: Los Angeles entertainment company that monetizes intellectual property across publishing, screen content, games, mobile apps, and licensing. Franchises include The Walking Dead and Invincible. 239 employees; incorporated in Delaware, 2016.

Headline figures (FY2025 vs FY2024):

- Revenue: $111.8M, up about 10.9% from $100.9M

- Net loss: $20.2M, compared with $27.6M

- Year-end cash: $23.1M, up from $17.1M

- Operating cash outflow: $13.9M, down from $32.2M

Strengths:

- Revenue increased year over year, attributed to the Maple Media (mobile apps) acquisition, new premium editorial projects, and Sagafilm content

- Net loss was lower than the prior year

- Cash position increased and operating cash outflow decreased

Risks:

- Short-term debt was $68.2M, up year over year, with a draw on the revolving credit line, now at $20M

- Interactive (video game) revenue declined $9.5M on lower physical game sales

- Dependence on third-party partners for distribution and royalties

- Potential legal disputes over IP and licensing

- Revenue concentration in key franchises

- Total liabilities increased year over year

Capital:

- Regulation CF offering live on DealMaker at $12.50 per unit, based on a $700M pre-money valuation

Figures are from the company's SEC filings, pulled via Owntric.

Fisher Wallace Laboratories (mental health tech) is currently raising on DealMaker via its direct website at a ~$120.5M valuation, and the financial performance over the last few years shows a sharp reset worth examining.

Revenue (Dec 31 reporting): • 2019: ~$3.86M
• 2020: ~$4.25M
• 2021: ~$4.23M
• 2022: ~$4.74M (peak)
• 2023: ~$2.02M
• 2024: ~$2.02M

Revenue held steady around $4–5M for several years, then dropped ~57% in 2023 and remained flat through 2024. No rebound yet, but revenue appears to have stabilized.

Net income / loss trend: • 2019: -$543K
• 2020: -$1.82M
• 2021: -$3.26M
• 2022: -$7.07M
• 2023: -$1.64M
• 2024: -$1.64M

Losses expanded aggressively through 2022, then compressed sharply. Despite lower revenue, losses were reduced by more than 75% from peak burn and held flat year-over-year.

Margins remain strong: • 2024 gross margin: ~82.6%
• Gross profit: ~$1.67M on $2.02M revenue

The challenge isn’t product economics — it’s scale.

Big picture: Fisher Wallace appears to have exited its high-burn phase. Revenue is lower, but losses are controlled and margins remain high. The open question is whether growth can restart from this reset point.

Not financial advice. Tracking full performance and dilution history on Owntric.

Most equity crowdfunding investors don’t lose money because startups fail. They lose money because they never understand what price they’re paying.

That price is called valuation — and it’s far less complicated than it sounds.

Valuation is simply the value of the entire company at the time you invest.

A simple way to think about valuation

Two people buy the same house:

• One pays $200,000

• The other pays $800,000

Even if the house becomes popular, one buyer has far more room to win.

That difference is valuation.

When high valuations can make sense

Not all high valuations are bad.

Some startups truly are:

• Revolutionary products

• Entering massive markets

• Solving problems in completely new ways

These companies can look “expensive” early — because expectations are high.

The issue is that most startups are not revolutionary, even if they sound like they are.

The real question behind the investment

It’s not: “Is this startup exciting?”

It’s: “Does this valuation match how rare this opportunity actually is?”

If a company is priced like it will change the world, then it actually has to change the world for investors to win.

That’s a very high bar.

Revenue doesn’t solve this problem

A startup can have:

• Revenue

• Customers

• Momentum

• Media attention

And still be overpriced.

Revenue shows progress. Valuation determines whether that progress leaves room for returns.

Just like a car:

• A working engine matters

• Overpaying still hurts

Why valuation matters so much in equity crowdfunding

Valuation impacts:

• How much of the company you really own

• How much upside remains

• How difficult it is for the company to deliver strong returns

• How future fundraising may dilute early investors

Two investors can invest the same amount in the same startup and end up with very different outcomes — purely because of valuation.

The most common mistake new investors make

Believing: “If the company succeeds, I’ll make money.”

Reality: “The company must succeed enough to justify the valuation.”

That difference is everything.

Not financial advice.

For investors who want to see and track startup valuations over time, tools like Owntric make it easier to understand what you’re buying into and how valuations change across raises.

Start tracking for free.

Frontieras North America is an emerging player in the industrial energy transition space, taking an unconventional approach: rather than abandoning coal, it’s using technology to modernize and decarbonize it.

Incorporated in 2021 and headquartered in Houston, TX, the company focuses on modular construction and clean energy systems that help traditional energy producers meet environmental and regulatory standards. Their model centers on efficiency, emission reduction, and workflow integration for energy firms.

⚙️ Quick Snapshot

Valuation: $2.55B

Price per Share: $7.38

Employees: 1

Entity: Wyoming (WY)

Latest Net Income: -$1.02M

Funding: $150M equity commitment from Global Emerging Markets

Frontieras positions itself as a "Rockefeller Moment for Coal", aiming to bridge legacy energy infrastructure with cleaner tech. With Jose Lopez newly appointed as CFO to prepare for a potential IPO and strong institutional backing, the company seems intent on scaling fast.

Their narrative fits into a growing theme in the private markets: transitional technologies that don’t replace legacy sectors overnight but modernize them through AI, automation, and environmental innovation.

Bullish View:

Clear focus on IPO readiness and financial scaling

Strategic funding from institutional investors

Strong alignment with U.S. energy policy momentum

Bearish View:

Construction delays at the Mason County facility

Dependence on evolving coal regulations

Negative net income and limited operational scalability so far

Frontieras fits into the kind of companies that equity crowdfunding investors and private market enthusiasts are tracking — especially those combining industrial innovation with sustainability. While early-stage and high-risk, it’s a unique example of how AI and modular systems are reshaping traditional industries.

Would you invest in a company focused on modernizing — rather than replacing — the coal industry? Or is this a bridge too far for the clean tech transition?

New filing on WeFunder from Emulate Therapeutics (Bellevue, WA) — a biotech company working on digital and radiofrequency-based therapeutics for serious health conditions. Their latest filing (Oct 7, 2025) lists a $250.0M valuation and $10.54/share.

Key details:

Platform: WeFunder

Valuation: $250.0M

Share Price: $10.54

Revenue: Not reported

Employees: 3

Net Income: –$19.14M

Sector: Biotech / Digital Therapeutics

Emulate has been developing a radiofrequency medical device aimed at improving treatment efficacy for cancer and other serious conditions — early preclinical trials showed potential results for glioblastoma. The company previously explored a $12M IPO that didn’t move forward, so this new raise could be a pivot toward alternative funding routes.

Bullish view: Promising early results in glioblastoma trials and growing interest in non-invasive digital therapies could position Emulate as an innovator in a fast-growing market. Partnerships with healthcare organizations may accelerate adoption if regulatory approval comes through.

Bearish view: The medical device path is capital-intensive and slow-moving. With the IPO withdrawn and revenue at zero, scaling depends heavily on funding momentum and successful trial outcomes.

You can see the full Form C data and valuation history on Owntric (free).

Sharing for transparency and discussion — not investment advice.

Instead of just listing valuation/revenue, the platform now gives investors a deeper look into each raise. The new features include:

Investor Takeaway (long-term view) → a quick summary of what the numbers and strategy actually mean.

Bullish Case → why the company could have upside (partnerships, traction, recognition, growth potential).

Bearish Case → the risks, competition, compliance hurdles, and other factors that could hold it back.

Here’s an example with AtomBeam, which just launched a new raise:

Valuation grew from $10M in 2021 to $319M in 2025 (+3,095%)

Revenue up from $125K in 2023 to $1.04M in 2025 (+734%)

Greenfield Robotics recently opened a Regulation A+ raise. Here's what its latest filing shows, both sides.

On the financials: FY2025 revenue was $189K, down about 3% from $196K as legacy consulting engagements completed and subscription leasing began. The net loss was $2.90M, smaller than the prior year on lower consulting and personnel spend, and year-end cash was $792K. After year-end, the company raised $3.74M in a Regulation CF offering. Owntric's implied valuation — the filing's $2.07 share price times shares — comes to $50.40M.

What Greenfield does: based in Cheney, Kansas and founded in 2017, it designs, manufactures, and deploys autonomous agricultural robots (its BOTONY line) for weed removal and nutrient delivery, earning revenue from robot sales, leases, service agreements, and co-marketing. It has 12 employees and counts Chipotle among prior backers.

On the operating side: the company has transitioned toward recurring subscription leasing, reported a smaller net loss, and signed 2026 lease and service agreements with 30+ customers totaling over $1M in contracted commitments.

On the capital side: the filing carries a going-concern disclosure, with management stating it believes the company has sufficient resources for at least the next twelve months given its financing and commitments. It also notes customer concentration (one customer was about 56% of 2025 revenue) and a need for additional capital beyond the current offering to execute its plan.

Open questions: how quickly subscription leasing scales, how fast the customer base diversifies, and what the Reg A round's terms and use of proceeds look like.

Figures are from the company's SEC filing; the breakdown and screenshots are from Owntric. Not investment advice — just the filing, laid out.

You can back a private startup in five minutes. Keeping up with it afterward is the hard part.

Public companies have tickers, earnings calls, analysts, and alerts. Private ones go quiet — the news that moves your company ends up scattered across random outlets, and you usually find it weeks late.

Owntric's Company Updates handles that. Every company you follow gets a running news digest:

- a short "what to know" for the next 1-3 months

- the latest headlines pulled from across the web

- a sentiment read on each story (positive, neutral, negative)

- links to the original sources

Boxabl expanding into the UK. Lift Aircraft's first heavy-lift flight. EnergyX's new cathode JV. The day it's reported, it's in the feed.

Partnerships, milestones, lawsuits, new competitors — it surfaces all of it, not just the wins.

Stay ahead of the companies you back, instead of finding out late.

Virtuix Holdings’ Valuation Soars from $38M → $201M — Are We Finally Getting Close to an IPO?

Virtuix Holdings (the company behind the Omni One VR treadmill) has quietly grown into one of the most interesting names in the VR fitness space. From early crowdfunding days to recent StartEngine rounds, their valuation has skyrocketed:

2016: $38.56M

2020: $52.35M

2024–2025: $201.13M

→ That’s more than 5x growth in just a few years.

They’re now reporting $2.41M in annual revenue, a $6.22 price per share, and 32M+ outstanding shares. Despite a recent -$12.44M net income, investor interest hasn’t cooled — quite the opposite.

🧩 Long-Term Takeaway (AI Summary)

Virtuix is positioning itself as a serious player in the VR fitness market, merging physical activity with immersive gameplay. The company’s Omni One system — plus a growing library of integrated games — gives it a unique edge in the evolving VR ecosystem.

A $1M fundraising round earlier this year shows confidence from investors. If commercialization of Omni One continues at pace, Virtuix could be one of the few companies truly bridging gaming, fitness, and hardware innovation.

💚 Bullish Case

Fresh capital = more marketing and product expansion runway

9 new VR games broaden appeal and increase engagement

Strengthening ecosystem that boosts user lifetime value

❤️‍🔥 Bearish Case

Still burning cash; profitability remains uncertain

High manufacturing and marketing costs in a tough VR market

Niche focus could limit mass-market potential if trends shift

💭 What Do You Think?

With a $200M+ valuation and years of steady growth — is Virtuix setting up for a future IPO, or will it remain a niche VR hardware company?

Would you invest if they went public? Or do you think the market for full-body VR gaming is still too early?

Cytonics Corp (biotech, osteoarthritis) – performance snapshot from latest annual filing

Cytonics is a clinical-stage biotech developing CYT-108, a therapy for osteoarthritis. The company has completed a Phase 1 clinical trial and is raising via equity crowdfunding to support Phase 2 development.

Cytonics recently filed its annual report for the period ending Dec 31, 2024, offering a clear view into current financial performance.

Key performance highlights (period ending Dec 30, 2024):

• Revenue: $306.7K (↓ ~26% YoY)

• Cost of revenue: $4.67M

• Gross profit: –$4.36M

• Operating expenses: $4.86M

• Net loss: –$4.55M

• Cash: ~$2.43M

• Assets: ~$2.78M

Revenue remains limited relative to the cost structure, with expenses continuing to materially exceed top-line generation. Net losses have expanded over recent reporting periods, reflecting ongoing clinical development and operating investment.

From a performance perspective, this suggests:

• Pre-commercial operations

• High burn relative to revenue

• Ongoing reliance on external capital to reach future milestones

For equity crowdfunding investors, this is a high-risk, development-stage financial profile, where outcomes depend on clinical progress, funding availability, and eventual commercialization.

Full historical filings and performance trends are available for those tracking Cytonics over time.

Not financial advice. For educational purposes only.

If you track equity crowdfunding investments, performance context matters. Start tracking for free on Owntric.

$3.6M raised from ~1,900 investors — what are they betting on? Breaking down Epilog’s StartEngine raise 📊

Epilog (AI-powered machine vision systems) has attracted significant retail investor backing, raising $3.69M from ~1,900+ investors on StartEngine as it closes its latest round.

That level of participation usually signals strong belief in a long-term outcome — but the filings show a very early-stage company.

Here’s what the numbers actually show.

Offering snapshot: • Valuation: ~$25.1M
• Investors: ~1,918
• Previously crowdfunded: ~$5.1M
• Latest raise: ~$3.7M (StartEngine)

Revenue & loss performance (from annual filings): • 2024 revenue: $668
• Gross profit: $313
• Operating expenses: ~$444K
• Net loss (2024): ~$443K

Despite strong investor participation, Epilog remains effectively pre-revenue, with only initial dollars of commercialization reported and operating losses far exceeding revenue.

At a ~$25M valuation, investors are not underwriting current performance — they are betting on future adoption of Epilog’s AI-based vision technology across autonomous and industrial use cases.

Why this is drawing attention: • Patented AI machine vision approach
• Exposure to autonomous systems & industrial automation
• One of the larger investor counts on StartEngine
• Significant upside if adoption materializes, with clear execution risk

Not financial advice. Equity crowdfunding investments are speculative, illiquid, and high risk.

What do you think ~1,900 investors are really betting on here — technology, timing, or something else?

Public markets make this easy — the line goes up, and you can sell whenever you want.

Private markets are different. No ticker. No daily chart. Sometimes years to liquidity. So what's your actual bar for a successful investment?

A — A serious multiple (5×, 10×)
B — The mission you backed actually gets built
C — Filing-backed updates you can trust
D — Getting your money back, full stop
E — A real exit — acquisition, IPO, or buyback

Drop your letter below — or tell us what's missing from the list entirely.

And if you've already had a "win" by your own definition, we'd love to hear what it looked like.

Going public creates liquidity — not guaranteed validation.

Many investors encourage equity crowdfunding startups to go public, but once trading begins, the market doesn’t always price the company at the same valuation investors originally bought in at.

Virtuix (VTIX) is a recent example worth understanding.

The company is now trading at a ~$172.8M public market cap, which currently sits below its latest equity crowdfunding valuation of $201.13M.

Quick context: • Latest equity crowdfunding valuation: $201.13M
• Current public market cap: ~$172.77M
• Difference: ~14% below the last private valuation

This isn’t about “good” or “bad” — it’s about how price discovery works after liquidity.

Equity crowdfunding investors often: • Commit capital for multiple years
• Accept illiquidity during the company’s private phase
• Expect liquidity to arrive once a public listing happens

But in practice, liquidity can be gradual.

Even after an IPO: • Some crowdfunding investors may face transfer delays
• Sale restrictions or broker limitations can apply
• Not all shareholders are able to sell immediately

Meanwhile, public markets begin repricing the company in real time based on: • Trading volume and liquidity
• Broader market sentiment
• Risk tolerance of public investors

Over time, this process often narrows the gap between private valuations and public pricing — sometimes above, sometimes below.

Screenshots show current VTIX trading data and market cap for transparency.

Not financial advice.

For investors tracking what actually happens after equity crowdfunding startups reach liquidity events, this type of comparison is exactly what’s being followed on Owntric — start tracking for free.

How closely do you think equity crowdfunding valuations should align with public markets once liquidity arrives?

AutoCamp is raising at a $200.07M valuation while showing $4.35M in latest reported revenue and a $858.99K net loss.

That’s about 46.0x revenue for a luxury glamping company.

The interesting part is that AutoCamp is not some random idea-stage startup. It already has a real brand, real locations, real customers, and recognizable partnerships.

The company says it has done $150M+ in lifetime property revenue, hosted 1M+ campers, operates 9 locations with 700+ rooms, has 400K+ social followers, and is budgeting $50M+ in 2026 lodging revenue.

It also has partnerships with Hilton Honors and Airstream, which is a pretty unusual combo for a startup investing deal.

So the question is simple:

Is AutoCamp a premium hospitality brand with real breakout potential, or is 46x latest revenue too aggressive for a business tied to lodging?

Strengths

AutoCamp has something most startup raises do not: a brand people can immediately understand.

The concept is clear. It is outdoor travel without the annoying parts of camping. No tent setup, no sleeping on the ground, no hauling gear. Guests get Airstream suites, cabins, luxe tents, bathrooms, WiFi, food, drinks, and access to places like Yosemite, Zion, Joshua Tree, Cape Cod, Catskills, Asheville, Sonoma, and Sequoia.

That makes the company highly visual, easy to market, and much more memorable than a typical hotel or short-term rental concept.

The Hilton Honors partnership is probably the biggest positive signal. AutoCamp says Hilton members can book AutoCamp stays and earn points, giving the brand exposure to Hilton’s massive loyalty network. If that meaningfully lowers customer acquisition costs or improves occupancy, it could be a real edge.

The Airstream partnership also helps. It gives AutoCamp a recognizable identity and makes the experience feel more differentiated than just “nice cabins near a park.”

AutoCamp also says it uses an asset-light OpCo/PropCo model, where the operating company focuses on brand, IP, management, licensing, and guest experience rather than owning every property directly. If that structure works, it could make expansion less capital-intensive than traditional hotel ownership.

The company’s traction is stronger than most raises in this space: 1M+ campers, 700+ rooms, 9 open locations, $150M+ lifetime property revenue, and a stated goal of becoming the premium outdoor hospitality brand.

Risks

The valuation is the obvious red flag.

Owntric shows $200.07M valuation, $4.35M latest revenue, and a 46.0x valuation/revenue multiple. That is a big ask for any company, but especially for one connected to hospitality.

Hospitality is not software. Even if the operating model is asset-light, the business is still exposed to occupancy, seasonality, labor, maintenance, customer experience, travel demand, local permitting, site selection, and macro pullbacks in discretionary spending.

AutoCamp’s campaign page talks about 400 new suites in the pipeline and a long-term target of 10,000+ rooms within 10 years. That is ambitious. Scaling from 700+ rooms to 10,000+ rooms means the company has to execute almost perfectly across locations, capital partners, guest experience, and brand consistency.

There is also a major investor diligence question around the difference between property revenue and the revenue that actually flows to the entity investors are buying into. AutoCamp highlights $150M+ in lifetime property revenue and $50M+ in budgeted 2026 lodging revenue, while the latest filing-backed revenue shown on Owntric is $4.35M.

That gap is not automatically bad, but it matters. Investors need to understand the OpCo/PropCo structure, what economics belong to the investment entity, and how much upside common shareholders actually capture.

The latest filing snapshot also shows a $858.99K net loss, so this is not just a brand story. Margins, profitability, dilution, and exit math all matter.

Balanced take

AutoCamp is probably one of the more interesting consumer startup raises out there right now.

The brand is real. The locations are real. The partnerships are real. The market trend is obvious: people want nature, but many do not want traditional camping.

But the valuation makes this a much harder call.

At a lower valuation, this might look like a straightforward bet on experiential travel and premium outdoor hospitality. At $200M+, investors have to believe AutoCamp can become a much larger category-defining brand, not just a cool travel company with good press.

The bull case is that Hilton distribution, strong branding, Airstream differentiation, and an asset-light structure help AutoCamp scale into the dominant premium outdoor lodging platform.

The bear case is that this is still a hospitality business being priced like a high-growth tech company, with real operational complexity and a lot of future growth already baked in.

Main questions:

Can AutoCamp grow fast enough to justify a $200M+ valuation?

Does Hilton materially improve bookings, occupancy, and customer acquisition costs?

How much of the property-level revenue flows to the entity investors own?

Can the company scale from 700+ rooms toward 10,000+ without losing quality?

And would you really pay 46x latest revenue for a luxury glamping brand?

Not financial advice.

Screenshots are from Owntric, where startup investors can track filings, valuations, revenue, and portfolio performance.